跳至主要内容
临床试验/IRCT20170202032367N2
IRCT20170202032367N2招募中3 期

Effect of l-carnitine supplementation on inflammatory markers, serum glucose and lipids in hemodialysis children

Tehran University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 years 至 18 years(—)
性别
All

入选标准

  • at least 2 times a week dialysis
  • three months pass after dialysis at least
  • plasma carnitine to carnitine free ratio greater than 0.4 (indicating a lack of carnitine)
  • desiring to participate in this study

排除标准

  • use of non-steroidal and steroidal anti-inflammatory, lipid lowering and beta-blocker medications
  • autoimmune diseases, infectious, inflammatory disease, cardiovascular disease, thyroid disorders, thrombocytopenia
  • nutritional support (enteral and parenteral nutrition)

研究者

相似试验